Get 50% OFF This Summer!

Advertisement
logo

Vaishali Pharma

VAISHALI
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement

Vaishali Pharma Share price and Fundamental Analysis

View All Details
View All Details
Vaishali Pharma Limited was originally incorporated as a private limited company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008. On July 01, 2008 the company acquired the business of proprietorship concerns of its promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently business of this proprietorship firm was merged into Vaishali Pharma Private Limited. Subsequently the company was converted into a public limited company and the name of the company was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the promoters of the company.
Company Incorporation2008
ChairmanAtul Vasani
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
139.35
PE Ratio
325
Industry P/E
34.61
PEG Ratio
-3.37
ROE
1.62%
ROCE
3.63%
ROA
0.41%
Total Debt (Cr)
13.12
Debt to Equity
0.19
Dividend Yield
0%
EPS
0.04
Book Value & P/B
6.1 x 2.13
Face Value
2
Outstanding Shares(Cr)
10.72
Current Ratio
4.3
EV to Sales
1.56

Stock Returns

1 Week+4.5%
1 Month+4.59%
6 Months-21.83%
1 Year-16.13%
3 Years+67.31%
5 Years+164.23%

CAGR

1 Year CAGR

Revenue Growth

+23.85%

Net Profit Growth

-89.11%

Operating Profit Growth

-72.08%

Dividend Growth

N/A

Stock Returns CAGR

-16.13%
no_data

No Stocks

Smart Score

1.6
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 26.32%

FIIs : 0.00%

DIIs : 0.00%

Public : 73.68%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Vaishali Pharma Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Vaishali Pharma Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Vaishali Pharma Limited was originally incorporated as a private limited company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008. On July 01, 2008 the company acquired the business of proprietorship concerns of its promoter Mr. Atul Vasani viz. M/s. Vaishali Pharmachem through Business Assignment agreement. Consequently business of this proprietorship firm was merged into Vaishali Pharma Private Limited. Subsequently the company was converted into a public limited company and the name of the company was changed to Vaishali Pharma Limited on 21st, June 2017. Atul Vasani and Jagruti Vasani are the promoters of the company.

Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. The Company is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For the export markets, the company gets the formulations manufactured by third parties whose facilities are approved and certified by the respective countries for developing the respective products. At present, the company has applied for 186 registrations in 13 countries for some of its product, out of which it has successfully received 71 approvals from 7 countries and in process of obtaining remaining approvals, which will give boost to export business operations.

Vaishali Pharma Share Price

Vaishali Pharma share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Vaishali Pharma Market Cap

Market capitalization of Vaishali Pharma indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Vaishali Pharma is valued compared to its competitors.

Vaishali Pharma PE Ratio

Vaishali Pharma PE ratio helps investors understand what is the market value of each stock compared to Vaishali Pharma 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Vaishali Pharma PEG Ratio

The PEG ratio of Vaishali Pharma evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Vaishali Pharma ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Vaishali Pharma generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Vaishali Pharma ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Vaishali Pharma in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Vaishali Pharma Total Debt

Total debt of Vaishali Pharma shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Vaishali Pharma Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Vaishali Pharma compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Vaishali Pharma CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Vaishali Pharma over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Vaishali Pharma Technical Analysis

Technical analysis of Vaishali Pharma helps investors get an insight into when they can enter or exit the stock. Key components of Vaishali Pharma Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Vaishali Pharma shares often struggle to rise above due to selling pressure.

Vaishali Pharma Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Vaishali Pharma ’s financial health and profitability.

Vaishali Pharma Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Vaishali Pharma Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Vaishali Pharma Financials

The financials of Vaishali Pharma provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Vaishali Pharma Profit and Loss Statements

The profit and loss statement of Vaishali Pharma highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Vaishali Pharma .

Vaishali Pharma Balance Sheet

The balance sheet presents a snapshot of Vaishali Pharma ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Vaishali Pharma Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App